Anionic Exchange-Hydrophobic Mixed Mode Ligands for Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying immunoglobulins and other proteins from biological samples, such as mammalian bodily fluids or cell culture harvests, are inefficient in separating monomeric antibodies from aggregates, leading to impurities in diagnostic and therapeutic applications.
Innovation Solution
Chromatographic solid supports linked to specific ligands, such as N-phenylethylenediamine or 2-phenoxyethylamine, are used to selectively bind and elute monomeric antibodies, allowing for effective separation from aggregates through controlled buffer conditions in bind-elute or flow-through modes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chromatographic methods are used to purify immunoglobulins, then the purification process can be performed, but the separation of monomeric antibodies from aggregates is inefficient and impurities remain in the final product
Solution Approach 1:
The patent employs a composite chromatographic medium combining anionic exchange ligands (e.g., N-phenylethylenediamine, 2-phenoxyethylamine) with hydrophobic interaction components. This mixed-mode approach creates a composite binding mechanism that simultaneously exploits electrostatic and hydrophobic interactions to achieve superior separation of monomeric antibodies from aggregates, resolving the contradiction between purification quality and separation efficiency.
Solution Approach 2:
The patent utilizes controlled buffer conditions with specific pH ranges (e.g., pH 7.0-8.0 for binding, pH 4.0-6.0 for elution) and salt concentrations to optimize the interaction between the chromatographic ligand and antibody molecules. By adjusting these parameters, the method achieves efficient selective binding of monomeric antibodies while allowing aggregates to pass through, thereby improving both purification quality and separation efficiency.
2Reliability
If existing chromatographic supports are used, then the purification process can be completed, but the final antibody preparation contains impurities unsuitable for diagnostic and therapeutic applications
Solution Approach 1:
The patent replaces conventional mechanical filtration or simple chromatographic methods with a chemically optimized mixed-mode chromatographic system. The specific ligand structure (e.g., N-phenylethylenediamine linked to solid support) creates selective chemical interactions that reliably separate monomeric antibodies from aggregates, ensuring the final product meets stringent reliability requirements for diagnostic and therapeutic applications.
3Manufacturing precision
If the chromatographic method uses specific ligand structures, then monomeric antibody separation is improved, but the method complexity increases
Solution Approach 1:
The patent segments the chromatographic medium into distinct functional components: the solid support matrix, the anionic exchange ligand (e.g., N-phenylethylenediamine or 2-phenoxyethylamine), and the buffer system. This segmentation allows each component to be optimized independently while maintaining overall simplicity in the chromatographic column configuration and operation, thereby achieving effective separation without excessive method complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described method achieves superior purification of monomeric antibodies by effectively separating them from aggregates, outperforming commercial products like Capto Adhere, resulting in high-quality, purified antibody preparations for diagnostic and therapeutic uses.
Implementation Method 1
anionic exchange-hydrophobic mixed mode
Implementation Method 2
anionic exchange-hydrophobic mixed mode
Implementation Method 3
Chromatographic solid supports linked to a ligand are provided
Data Source
AI summary
Solid supports and ligands are provided for purification of biomolecules by mixed-mode anion exchange-hydrophobic chromatography. Compositions can have the formula Support-(X)—N(R1, R2)-R3-L-Ar, or a salt thereof, wherein: Support is a chromatographic solid support; X is a spacer or absent; R1 and R2 are each selected from hydrogen and an alkyl comprising 1-6 carbons; R3 is an alkyl comprising 1-6 carbons or a cyclo alkyl comprising 1-6 carbons; L is NR4, O, or S; wherein R4 is hydrogen or an alkyl comprising 1-6 carbons; and Ar is an aryl. Methods are also provided for using solid supports and ligands to purify biomolecules such as monomeric antibodies.